HUMBLEYARD PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: D82064 | NORWICH, NR4 6TA
Showing results 551-600 of 711
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Potassium chloride | 26 | 2,930 | £1.4K | +39.1% ▲ |
| Other calcium supplement preparations | 26 | 1,410 | £630 | +246.7% ▲ |
| Ready to serve 1.5 kcal/ml juice style (0913021) | 26 | 73.6K | £1.8K | +423.8% ▲ |
| Mupirocin | 26 | 450 | £181 | +180.0% ▲ |
| 26 | 170 | £29 | -10.2% ▼ | |
| Prazosin hydrochloride | 25 | 1,390 | £60 | +48.4% ▲ |
| Indacaterol/glycopyrronium | 25 | 750 | £772 | -44.6% ▼ |
| Cabergoline | 25 | 200 | £427 | +61.2% ▲ |
| Leuprorelin acetate | 25 | 25 | £4.5K | -46.1% ▼ |
| Ascorbic acid | 25 | 1,064 | £1.3K | +21.8% ▲ |
| Fludroxycortide | 25 | 736 | £566 | +137.1% ▲ |
| Doxycycline monohydrate | 24 | 834 | £449 | +121.0% ▲ |
| Mercaptopurine | 24 | 996 | £427 | +55.0% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 24 | 1,020 | £2.4K | -3.2% ▼ |
| Fluocinolone acetonide | 24 | 870 | £144 | +120.4% ▲ |
| 24 | 380 | £917 | -39.0% ▼ | |
| 24 | 4,835 | £7.9K | +13.4% ▲ | |
| 24 | 523 | £473 | +15.2% ▲ | |
| Nizatidine | 23 | 1,170 | £591 | -33.1% ▼ |
| Ofloxacin | 23 | 644 | £719 | +179.9% ▲ |
| Oestrogens conjugated | 23 | 2,016 | £830 | +12.7% ▲ |
| Zinc sulfate monohydrate | 23 | 1,890 | £354 | +159.6% ▲ |
| Vitamin B compound | 23 | 644 | £19 | -83.5% ▼ |
| Sodium chloride | 23 | 780 | £491 | -22.7% ▼ |
| 23 | 38 | £673 | +238.1% ▲ | |
| Ketotifen fumarate | 22 | 3,700 | £274 | +152.8% ▲ |
| Guanfacine | 22 | 616 | £1.2K | -14.4% ▼ |
| Estradiol valerate | 22 | 1,862 | £150 | +12.6% ▲ |
| Powder preterm infant formula (0913111) | 22 | 76.0K | £1.2K | +38.1% ▲ |
| 22 | 2,900 | £426 | -43.5% ▼ | |
| Naloxegol | 21 | 596 | £1.0K | +52.3% ▲ |
| Propafenone hydrochloride | 21 | 1,470 | £212 | +93.9% ▲ |
| Levomepromazine maleate | 21 | 1,008 | £270 | +128.7% ▲ |
| Zonisamide | 21 | 2,366 | £1.1K | -51.9% ▼ |
| Denosumab | 21 | 21 | £3.5K | -22.8% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 21 | 1,570 | £77 | +39.8% ▲ |
| Mupirocin | 21 | 63 | £85 | +78.9% ▲ |
| 21 | 510 | £220 | +532.4% ▲ | |
| Perampanel | 20 | 6,856 | £2.5K | -7.7% ▼ |
| Oxytetracycline | 20 | 2,744 | £1.3K | -22.6% ▼ |
| Tube feed 1.2 kcal/ml with fibre (0914021) | 20 | 276.0K | £4.7K | +57.4% ▲ |
| Acrivastine | 19 | 972 | £285 | +54.2% ▲ |
| Dexamethasone phosphate | 19 | 230 | £212 | +316.5% ▲ |
| Hydrocortisone sodium phosphate | 19 | 60 | £120 | +355.3% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 19 | 1,260 | £161 | +119.0% ▲ |
| 19 | 321 | £117 | -81.4% ▼ | |
| 19 | 2,083 | £3.9K | -52.4% ▼ | |
| 19 | 2,075 | £508 | -43.1% ▼ | |
| 19 | 210 | £283 | +96.7% ▲ | |
| Modafinil | 18 | 1,166 | £86 | -13.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.